http://cimzia.legalview.com/news-articles/ 2012-02-23 http://cimzia.legalview.com/news-articles/2010aeenauaoooiiaia-euiioouo-euiie/1323893/ 2012-02-23 http://cimzia.legalview.com/news-articles/article-nice-turns-down-b-ms-orencia-as-second-line-ra-option/1323892/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-chief-executive-doliveux-sees-10-years-of-growth-tijd-says-bloombe/1323891/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-ltd-xoma-shares-fall-459-hits-291-8211-american-banking-news/1323890/ 2012-02-23 http://cimzia.legalview.com/news-articles/tnf-blockers-get-an-added-warning-facts-fears-acsh/1323889/ 2012-02-23 http://cimzia.legalview.com/news-articles/cimziareg-certolizumab-pegol-de-ucb-pharma-indicado-para-el-tratamient/1302760/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-ltd-xoma-downgraded-by-canaccord-genuity-to-8220hold8221-8211-ame/1302759/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-ltd-xoma-posts-large-volume-increase-hits-521-8211-american-banki/1296634/ 2012-02-23 http://cimzia.legalview.com/news-articles/pipelinereviewcom-biotech-news-amp-online-store-top-30-biologics-2010/1296633/ 2012-02-23 http://cimzia.legalview.com/news-articles/cochrane-review-points-to-need-for-biologics-registries-a-irish-medica/1296632/ 2012-02-23 http://cimzia.legalview.com/news-articles/tmd-a-todayas-medical-developments-news/1296631/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-reports-strong-financial-performance-in-2010/1296630/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-wins-design-award-for-cimzia-syringe-and-packaging/1296629/ 2012-02-23 http://cimzia.legalview.com/news-articles/59-madicaments-placas-sous-surveillance-en-france/1275503/ 2012-02-23 http://cimzia.legalview.com/news-articles/assessment-of-self-injection-experience-in-patients-with-rheumatoid-ar/1275502/ 2012-02-23 http://cimzia.legalview.com/news-articles/week-of-jan-10-2011-company-and-people-notes-eli-lilly-and-boehringer/1275501/ 2012-02-23 http://cimzia.legalview.com/news-articles/nasdaq-unusual-volume-stocks-8211-dndn-life-joyg-bpax-xoma-savvy-stock/1275500/ 2012-02-23 http://cimzia.legalview.com/news-articles/study-finds-skin-lesions-troublesome-for-patients-taking-anti-tnf-drug/1275499/ 2012-02-23 http://cimzia.legalview.com/news-articles/ssn-plg-posc-xoma-ecob-price-jumps-at-nasdaq-and-nyse-topnews/1271697/ 2012-02-23 http://cimzia.legalview.com/news-articles/medical-news-new-ra-response-score-validated-in-rheumatology-arthritis/1271696/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucbs-cimzia-and-centocors-simponi-penetrate-first-line-biologic-positi/1271695/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-to-increase-cimzia-manufacturing-capacity/1268131/ 2012-02-23 http://cimzia.legalview.com/news-articles/biotrends-report-newer-anti-tnf-alpha-agents-simponi-and-cimzia-begin/1268130/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-plans-a250m-plant-to-meet-cimzia-demand-inpharm/1268129/ 2012-02-23 http://cimzia.legalview.com/news-articles/accesocom-cimzia-certolizumab-pegol-de-ucb-pharma-indicado-para-el-tra/1256801/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-issued-two-new-us-patents-covering-xoma-052-marketwatch/1256800/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-announces-presentation-and-webcast-at-lazard-capital-markets-7th/1256799/ 2012-02-23 http://cimzia.legalview.com/news-articles/new-8216patient-access-scheme8217-is-launched-a-irish-medical-times/1256798/ 2012-02-23 http://cimzia.legalview.com/news-articles/log-in-problems/1256797/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-appoints-timothy-p-walbert-to-its-board-of-directors-marketwatch/1256796/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-reports-third-quarter-2010-financial-results-marketwatch/1256795/ 2012-02-23 http://cimzia.legalview.com/news-articles/belgiums-ucb-updates-on-cimzia-and-epratuzumab-trials-pharmaceutical-a/1256794/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-to-announce-2010-third-quarter-financial-results-and-host-webcast/1252227/ 2012-02-23 http://cimzia.legalview.com/news-articles/eac-cyasaaasieyasea/1248408/ 2012-02-23 http://cimzia.legalview.com/news-articles/ibucbapuuo3aafneowagpav-gsd-nownews-esdo/1248407/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-agrees-neurology-partnership-with-synosia-therapeutics/1248406/ 2012-02-23 http://cimzia.legalview.com/news-articles/nektar-presents-new-preclinical-data-on-nktr-181-at-anesthesiology-201/1248405/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-announces-presentation-and-webcast-at-newsmakers-in-the-biotech-i/1248404/ 2012-02-23 http://cimzia.legalview.com/news-articles/medical-news-acg-certolizumab-heals-crohnaposs-ulcers-in-meeting-cover/1248403/ 2012-02-23 http://cimzia.legalview.com/news-articles/salut-i-forca-la-predictibilidad-del-tratamiento-para-la-artritis-reum/1244201/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-announces-presentation-and-webcast-at-bio-investor-forum-marketwa/1244200/ 2012-02-23 http://cimzia.legalview.com/news-articles/incyte-pharmaceuticalsa-jak-just-another-kinase-seeking-alpha/1244199/ 2012-02-23 http://cimzia.legalview.com/news-articles/nektar-therapeutics-to-present-at-the-ubs-2010-global-life-sciences-co/1240077/ 2012-02-23 http://cimzia.legalview.com/news-articles/arch-dermatol-sign-in-page/1240076/ 2012-02-23 http://cimzia.legalview.com/news-articles/gastroenterology-endoscopy-news/1231970/ 2012-02-23 http://cimzia.legalview.com/news-articles/the-drama-of-ratings-splits-and-new-wells-spmd-xomad-rexx-small-cap-st/1231969/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-regains-nasdaq-compliance-marketwatch/1231968/ 2012-02-23 http://cimzia.legalview.com/news-articles/inflammatory-bowel-diseases-common-in-area-inforum-fargo-nd/1231967/ 2012-02-23 http://cimzia.legalview.com/news-articles/brazil-pharmaceuticals-and-healthcare-report-q1-2010-new-market-report/1228533/ 2012-02-23 http://cimzia.legalview.com/news-articles/enzon-pharma-rd-spending-will-eventually-pay-off-seeking-alpha/1228532/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-appoints-jack-l-wyszomierski-to-its-board-of-directors-marketwatc/1228531/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-announces-reverse-stock-split-marketwatch/1225015/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-receives-4-million-for-sale-of-royalty-interest-in-cimziar-earth/1225014/ 2012-02-23 http://cimzia.legalview.com/news-articles/streetinsidercom-xoma-reports-second-quarter-2010-financial-results/1221820/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-reports-second-quarter-2010-financial-results-marketwatch/1221819/ 2012-02-23 http://cimzia.legalview.com/news-articles/uk-trust-sues-ucb-for-royalties-on-cimzia-fiercepharma/1221818/ 2012-02-23 http://cimzia.legalview.com/news-articles/nasdaq-major-corrections-of-the-day-drys-bios-rfmd-fcel-xoma-penny-sto/1218449/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-052-orphan-drug-designation-for-behcets-disease-recommended-by-eu/1218448/ 2012-02-23 http://cimzia.legalview.com/news-articles/cimzia-matches-simponi-on-key-performance-metrics-in-the-treatment-of/1218447/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-to-announce-2010-second-quarter-financial-results-and-host-webcas/1218446/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-052-designated-orphan-drug-by-fda-for-treatment-of-behcets-diseas/1218445/ 2012-02-23 http://cimzia.legalview.com/news-articles/stocks-touching-their-new-low-xoma-vgz-chs-ady-musa-penny-stock-live/1215117/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-enters-into-30-million-committed-equity-financing-facility-market/1215116/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-receives-750000-milestone-payment-from-aveo-pharmaceuticals-marke/1215115/ 2012-02-23 http://cimzia.legalview.com/news-articles/ieii-eeiis-ei-i-isi-3-eeiis-ei-i-iei-ii-ii/1211290/ 2012-02-23 http://cimzia.legalview.com/news-articles/de-standaard-online/1211289/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-pharma-lanza-en-espa241a-39cimzia39-un-f225rmaco-biol243gico-de-di/1211288/ 2012-02-23 http://cimzia.legalview.com/news-articles/nktr-102-demonstrates-superior-activity-to-irinotecan-in-nonclinical-s/1211287/ 2012-02-23 http://cimzia.legalview.com/news-articles/log-in-problems/1211286/ 2012-02-23 http://cimzia.legalview.com/news-articles/fda-finally-admits-that-drugs-for-crohns-disease-and-arthritis-may-pro/1204061/ 2012-02-23 http://cimzia.legalview.com/news-articles/cimzia-en-oxo-good-grips-maken-het-de-reuma-patient-gemakkelijk-medica/1200774/ 2012-02-23 http://cimzia.legalview.com/news-articles/news-sustained-improvements-observed-in-patients-with-ra-treated-with/1200773/ 2012-02-23 http://cimzia.legalview.com/news-articles/fda-finally-admits-that-drugs-for-crohns-disease-and-arthritis-may-pro/1200772/ 2012-02-23 http://cimzia.legalview.com/news-articles/postbulletincom-rochester-mn/1200771/ 2012-02-23 http://cimzia.legalview.com/news-articles/theres-usually-lots-of-special-situations-in-the-biotrch-sector/1200770/ 2012-02-23 http://cimzia.legalview.com/news-articles/two-year-cimzia-certolizumab-pegol-data-from-study-showed-sustained-im/1200769/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-increases-stake-in-wilex/1196406/ 2012-02-23 http://cimzia.legalview.com/news-articles/expertos-en-artritis-reumatoide-abogan-por-el-uso-de-terapias-biol243g/1192035/ 2012-02-23 http://cimzia.legalview.com/news-articles/abstract-published-on-initial-results-from-xoma-052-clinical-trial-in/1192034/ 2012-02-23 http://cimzia.legalview.com/news-articles/de-standaard-online-paardenmiddel-is-doorgeslikt/1192033/ 2012-02-23 http://cimzia.legalview.com/news-articles/nktr-102-phase-2-clinical-data-accepted-for-oral-presentation-at-2010/1192032/ 2012-02-23 http://cimzia.legalview.com/news-articles/despite-safety-concerns-actemra-usage-increases-among-tnf-refractory-p/1192031/ 2012-02-23 http://cimzia.legalview.com/news-articles/nektar-therapeutics-president-and-ceo-howard-w-robin-to-present-at-the/1192030/ 2012-02-23 http://cimzia.legalview.com/news-articles/pr-canadanet-nektar-therapeutics-president-and-ceo-howard-w-robin-to-p/1192029/ 2012-02-23 http://cimzia.legalview.com/news-articles/el-boom-de-las-modelos-maduras-lanacioncom/1187901/ 2012-02-23 http://cimzia.legalview.com/news-articles/generation-b-for-boomer-models-its-boom-time-nytimescom/1182383/ 2012-02-23 http://cimzia.legalview.com/news-articles/log-in-problems/1178417/ 2012-02-23 http://cimzia.legalview.com/news-articles/news-belgian-study-confirms-efficacy-of-certolizumab-for-crohns-diseas/1178416/ 2012-02-23 http://cimzia.legalview.com/news-articles/abstract-published-on-initial-results-from-xoma-052-clinical-trial-in/1178415/ 2012-02-23 http://cimzia.legalview.com/news-articles/despite-safety-concerns-actemra-usage-increases-among-tnf-refractory-p/1178414/ 2012-02-23 http://cimzia.legalview.com/news-articles/abstract-published-on-initial-results-from-xoma-052-clinical-trial-in/1178413/ 2012-02-23 http://cimzia.legalview.com/news-articles/new-study-by-biotrends-highlights-the-risk-of-tnf-alpha-inhibitors-of/1178412/ 2012-02-23 http://cimzia.legalview.com/news-articles/stockexploder-stocks-to-watch-for-04162010gwsccgpilhptxoma-tradingmark/1173723/ 2012-02-23 http://cimzia.legalview.com/news-articles/otc-tip-reporter-reports-active-stocks-to-watch-for-april-19-2010-are/1173722/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-issued-two-new-us-patents-for-methods-of-treating-type-2-diabetes/1173721/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-052-mechanism-of-action-results-published-in-journal-of-biologica/1173720/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-shares-fall-on-fda-request-for-neupro-drug-reformulation-wsjcom/1173719/ 2012-02-23 http://cimzia.legalview.com/news-articles/long-term-data-on-cimziar-certolizumab-pegol-for-moderate-to-severe-cr/1173718/ 2012-02-23 http://cimzia.legalview.com/news-articles/medical-news-ddw-anti-tnf-agent-recaptures-response-in-crohnaposs-dise/1173717/ 2012-02-23 http://cimzia.legalview.com/news-articles/nektar-therapeutics-reports-first-quarter-2010-financial-results-marke/1173716/ 2012-02-23 http://cimzia.legalview.com/news-articles/officialwire-company-financials-nektar-therapeutics-new-report-publish/1173715/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-interim-report-cimzia-vimpat-and-neupro-build-momentum/1173714/ 2012-02-23 http://cimzia.legalview.com/news-articles/new-efficacy-data-shows-cimziar-certolizumab-pegol-provides-long-term/1173713/ 2012-02-23 http://cimzia.legalview.com/news-articles/osiris-resumes-enrollment-in-stem-cell-trial-for-crohns-disease-follow/1173712/ 2012-02-23 http://cimzia.legalview.com/news-articles/watch-list-xoma-limited-nasdaqxoma-penny-stock-live/1170256/ 2012-02-23 http://cimzia.legalview.com/news-articles/xoma-to-announce-2010-first-quarter-financial-results-and-host-webcast/1170255/ 2012-02-23 http://cimzia.legalview.com/news-articles/biologicals-continue-to-change-the-therapeutic-picture-for-autoimmunit/1170254/ 2012-02-23 http://cimzia.legalview.com/news-articles/new-data-on-cimzia-for-crohns-disease-treatment-to-be-demonstrated-at/1170253/ 2012-02-23 http://cimzia.legalview.com/news-articles//1167462/ 2012-02-23 http://cimzia.legalview.com/news-articles/overvakingslisten-er-oppdatert-relis-produsentuavhengig-legemiddelinfo/1167461/ 2012-02-23 http://cimzia.legalview.com/news-articles/exagen-debuts-molecular-test-to-distinguish-ibd-subtypes-eyes-companio/1167460/ 2012-02-23 http://cimzia.legalview.com/news-articles/mme-hires-crystal-zheng-as-digital-media-planner-webnewswirecom/1167459/ 2012-02-23 http://cimzia.legalview.com/news-articles/fastmoneytalkcom-smokefree-innotec-inc-ampamp-xoma-ltd-group-profiled/1164450/ 2012-02-23 http://cimzia.legalview.com/news-articles/jpmorgan-hebt-ziel-fr-ucb-auf-32-euro-underweight/1161863/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-pharma-cimzia-subventioneras-och-finns-nu-tillganglig-i-sverige-my/1161862/ 2012-02-23 http://cimzia.legalview.com/news-articles//1158850/ 2012-02-23 http://cimzia.legalview.com/news-articles//1158849/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-be0003739530-ucb-ucb-declasse-d039acheter-a-neutre-par-nomura-reco/1158848/ 2012-02-23 http://cimzia.legalview.com/news-articles/pr-canadanet-orencia-early-leader-among-new-biologics-to-treat-rheumat/1158847/ 2012-02-23 http://cimzia.legalview.com/news-articles/arzneimittelspritze-gegen-rheumatoide-arthritis-gewinnt-designpreis-au/1155471/ 2012-02-23 http://cimzia.legalview.com/news-articles//1155470/ 2012-02-23 http://cimzia.legalview.com/news-articles//1155469/ 2012-02-23 http://cimzia.legalview.com/news-articles/xyzal-campaign-to-give-allergies-a-clean-sweep-medical-marketing-and-m/1155468/ 2012-02-23 http://cimzia.legalview.com/news-articles/hospital-healthcare-europe-ucb-solid-foundation-for-sustainable-growth/1152599/ 2012-02-23 http://cimzia.legalview.com/news-articles/presseportal-ucb-pharma-arzneimittelspritze-gegen-rheumatoide-arthriti/1148955/ 2012-02-23 http://cimzia.legalview.com/news-articles/arthritis-bowel-diseases-linked-columns/1148954/ 2012-02-23 http://cimzia.legalview.com/news-articles/arthritis-sufferers-see-new-hope-topnews-united-states/1148953/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-accelere-sa-transformation-en-leader-mondial-biopharmaceutique-axe/1142830/ 2012-02-23 http://cimzia.legalview.com/news-articles/ucb-innovative-payment-scheme-behind-cimzia-approval-sets-precedent-in/1142829/ 2012-02-23 http://cimzia.legalview.com/news-articles/columnists-newsjournalonlinecom/1142828/ 2012-02-23 http://cimzia.legalview.com/news-articles/xomas-past-present-and-future-seeking-alpha/1142827/ 2012-02-23